Molina Healthcare (NYSE:MOH) Stock Rating Lowered by Wall Street Zen

by · The Cerbat Gem

Wall Street Zen downgraded shares of Molina Healthcare (NYSE:MOH – Free Report) from a buy rating to a hold rating in a research note published on Sunday.

Several other brokerages also recently commented on MOH. Truist Financial raised their price objective on Molina Healthcare from $340.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Mizuho lifted their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an “outperform” rating in a research note on Wednesday, April 9th. Sanford C. Bernstein assumed coverage on Molina Healthcare in a research note on Tuesday, April 22nd. They issued an “outperform” rating and a $414.00 price target on the stock. Robert W. Baird reissued a “neutral” rating and issued a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Finally, Baird R W downgraded Molina Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Ten analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, Molina Healthcare has an average rating of “Hold” and a consensus target price of $364.21.

Check Out Our Latest Stock Analysis on MOH

Molina Healthcare Stock Performance

Shares of Molina Healthcare stock opened at $306.37 on Friday. The company has a market capitalization of $16.61 billion, a PE ratio of 14.79, a PEG ratio of 1.00 and a beta of 0.55. Molina Healthcare has a 12 month low of $262.32 and a 12 month high of $365.23. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.87. The stock’s fifty day simple moving average is $307.13 and its 200 day simple moving average is $306.69.

Molina Healthcare (NYSE:MOH – Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion for the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The firm’s revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the business posted $5.73 EPS. On average, research analysts predict that Molina Healthcare will post 24.4 EPS for the current year.

Insider Activity

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm’s stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total value of $28,005,250.00. Following the completion of the transaction, the chief executive officer owned 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the firm’s stock in a transaction dated Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the transaction, the director owned 11,244 shares of the company’s stock, valued at $3,603,702. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.26% of the stock is owned by company insiders.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds have recently modified their holdings of MOH. Price T Rowe Associates Inc. MD grew its holdings in shares of Molina Healthcare by 46.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company’s stock valued at $1,264,214,000 after acquiring an additional 1,216,903 shares in the last quarter. GAMMA Investing LLC grew its holdings in Molina Healthcare by 74,593.7% during the first quarter. GAMMA Investing LLC now owns 667,015 shares of the company’s stock worth $219,708,000 after purchasing an additional 666,122 shares during the period. Norges Bank bought a new position in Molina Healthcare during the fourth quarter worth about $134,675,000. FMR LLC grew its holdings in Molina Healthcare by 31.1% during the fourth quarter. FMR LLC now owns 1,801,113 shares of the company’s stock worth $524,214,000 after purchasing an additional 427,276 shares during the period. Finally, Voloridge Investment Management LLC grew its holdings in Molina Healthcare by 1,641.3% during the fourth quarter. Voloridge Investment Management LLC now owns 409,807 shares of the company’s stock worth $119,274,000 after purchasing an additional 386,273 shares during the period. Institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles